Contributions of Prolonged Contingent and Noncontingent Cocaine Exposure to Enhanced Reinstatement of Cocaine Seeking in Rats
Overview
Authors
Affiliations
Rationale: Recent evidence suggests that prolonged cocaine self-administration produces escalation in drug-seeking behavior in rats analogous to the increased intake patterns observed in cocaine-dependent individuals. However, the contributions of prolonged access to cocaine taking vs the pharmacologic effects of the consequent increased cocaine exposure on escalation of drug-seeking behaviors have not been investigated.
Objective: The present study assessed the effects of these two factors on maintenance of cocaine self-administration and reinstatement of cocaine seeking.
Methods: Male, Sprague-Dawley rats were trained to self-administer cocaine (0.2 mg/i.v. infusion; FR1) for 1 h per day for 10 sessions followed by short access (1 h/day), contingent long access (6 h/day), or noncontingent long access (1 h contingent + 5 h of yoked cocaine infusions/day; i.e., short access + yoked) to cocaine for 14 daily sessions. All rats underwent extinction training and were subsequently tested for the ability of cocaine-paired cues or a cocaine-priming injection (7.5 mg/kg i.p.) to reinstate extinguished cocaine seeking.
Results: Rats in all groups maintained stable responding for cocaine reinforcement and subsequently showed significant reinstatement of cocaine-seeking behavior. Conditioned-cued reinstatement was enhanced after the contingent long access and short access + yoked cocaine exposure relative to short access cocaine exposure. Conversely, cocaine-primed reinstatement was enhanced after contingent long-access cocaine exposure relative to the other two conditions.
Conclusions: Enhanced drug seeking produced by prolonged daily cocaine self-administration is due to a combination of behavioral and pharmacological factors. Specifically, conditioned-cued reinstatement is enhanced by increased cocaine intake and cocaine-primed reinstatement is enhanced by increased cocaine taking.
Doyle M, Beltran N, Bushnell M, Syed M, Acosta V, Desai M Drug Alcohol Depend. 2024; 263():112408.
PMID: 39141975 PMC: 11714059. DOI: 10.1016/j.drugalcdep.2024.112408.
Vendruscolo L, Vendruscolo J, Whiting K, Acri J, Volkow N, Koob G Psychopharmacology (Berl). 2024; 241(11):2303-2313.
PMID: 38869515 PMC: 11513716. DOI: 10.1007/s00213-024-06634-5.
Doyle M, Beltran N, Bushnell M, Syed M, Acosta V, Desai M bioRxiv. 2024; .
PMID: 38496609 PMC: 10942381. DOI: 10.1101/2024.03.04.583431.
Beasley M, Gunawan T, Tunstall B, Kearns D Learn Behav. 2022; 50(4):509-523.
PMID: 35132517 PMC: 10237344. DOI: 10.3758/s13420-022-00512-w.
OConnor S, Aston-Jones G, James M Neuropharmacology. 2021; 195:108566.
PMID: 33862028 PMC: 8410649. DOI: 10.1016/j.neuropharm.2021.108566.